Phibro Animal Health (PAHC) Stock
Animal health company supplying vaccines and feed additives. Here's the price, business snapshot, and what's worth knowing about Phibro Animal Health in June 2026.
Phibro Animal Health Corp (PAHC) is a mid-cap company focused on animal health, mineral nutrition and performance solutions for livestock and companion animals. Investors should know it supplies vaccines, feed additives and pharmaceutical products alongside technical services to farmers, integrators and distributors. Its performance is tied to global demand for protein, livestock herd sizes and feed input costs, and it has exposure to emerging markets where growth in meat and dairy consumption can be faster. Profitability can be sensitive to commodity cycles, regulatory approvals and competitive pressures from larger animal-health groups. With a market capitalisation around $1.7bn, PAHC may appeal to investors seeking sector-specific exposure rather than diversified healthcare coverage. Consider this as an educational overview: values can rise and fall, past performance does not predict the future, and this is not personalised investment advice. Review company reports, recent results and sector peers before making decisions.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Phibro Animal Health's stock with a target price of $43, indicating strong growth potential.
Financial Health
Phibro Animal Health Corp shows solid revenue and cash flow, indicating good financial performance.
Dividend
Phibro Animal Health Corp's dividend yield of 1.52% is decent for those seeking some income from their investment. If you invested $1000 you would be paid $15.20 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
AbbVie
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
ASTRAZENECA PLC
AstraZeneca is a global biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative medicines.
AMGEN INC
Amgen is a global biotechnology company that focuses on discovering, developing and commercializing treatments for unmet medical needs.
Baskets Featuring PAHC
Next-Gen Proteins
Looking to invest in the future of food? This carefully selected group of stocks represents companies solving our global protein challenges. From plant-based alternatives to agricultural innovation, these stocks have been thoughtfully chosen by our analysts for their potential in this growing market.
Published: 17 June 2025
Explore BasketPets Are Family
The emotional bond with our furry companions has created a powerful, recession-resistant market. These carefully selected companies provide essential veterinary care, nutrition, and wellness services that pet owners prioritize regardless of economic conditions.
Published: 17 June 2025
Explore BasketWhy You’ll Want to Watch This Stock
Livestock demand story
Global demand for meat and dairy can support sales of vaccines and feed additives, though results vary with commodity cycles and herd sizes.
Emerging market exposure
Sales growth may come from faster-expanding markets abroad, but exposure brings currency, regulatory and distribution risks.
Innovation and approvals
New product development and regulatory clearances can drive revenue, yet R&D and approval timing add uncertainty to earnings.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
